Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2016, vol. 22, issue 2
Subject Area: Medicine
Pages: 1157-1159
DOI: 10.5272/jimab.2016222.1157
Published online: 15 June 2016

J of IMAB 2016 Apr-Jun;22(2):1157-1159
Neli M. Ermenlieva1 Corresponding Autor, Tatina T. Todorova2, Gabriela S. Tsankova2, Tsvetelina K. Popova1, Emilia P. Georgieva1.
1) Medical College, Medical University Varna, Bulgaria
2) Department of Preclinical and Clinical Sciences, Faculty of Pharmacy, Medical University Varna, Bulgaria.

Methicillin-resistant Staphylococcus aureus (MRSA) are bacteria, responsible for severe and hard-to-manage infections in human. They are resistant to beta-lactam antibiotics – penicillins (methicillin, dicloxacillin, nafcillin, and oxacillin), cephalosporins and carbapenems, but can also be resistant to the new-generation MRSA-active cephalosporins (such as ceftaroline) or other groups of antibiotics, including aminoglycosides, macrolides, clindamycin, amphenicols, quinolones and tetracyclines. MRSA bacteria are pandemic and are often isolated in medical practice and nosocomial infections.
The MRSA detection is a challenge to any clinical microbiology laboratory and demands implementation of strict protocols for active screening. While more expensive molecular techniques have the potential of offering highly sensitive and rapid results, the cultural methods require longer time but can achieve a comparable sensitivity for lower price.

Key words: Methicillin-resistant Staphylococcus aureus, drug resistance, MRSA detection methods,

- Download FULL TEXT /PDF 768 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Ermenlieva NM, Todorova TT, Tsankova GS, Popova TK, Georgieva EP. Effectiveness of MRSA detection methods in the laboratory practice – a brief review. J of IMAB. 2016 Apr-Jun;22(2):1157-1159. DOI:

Correspondence to: Neli Mitkova Ermenlieva, Medical College, Medical University – Varna; 55, Marin Drinov Str., 9002 Varna, Bulgaria; E-mail:

1. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008 Jan;46(2):155-64. [PubMed]
2. Klevens R, Morrison M, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007 Oct;298(15):1763-71. [PubMed]
3. Russell AB, Sharland M, Heath PT. Improving antibiotic prescribing in neonatal units: time to act. Arch Dis Child Fetal Neonatal Ed. 2012 Mar; 97(2):141-6. [PubMed]
4. Gray J, Patel M. Management of antibiotic-resistant infection in the newborn. Arch Dis Child Educ Pract Ed. 2011 Aug;96(4):122-7. [PubMed]
5. Patel SJ, Saiman L. Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. Clin Perinatol. 2010 Sep;37(3):547-63. [PubMed]
6. Centers for Disease Control and Prevention. Laboratory Testing for MRSA | MRSA | CDC [Internet]. 2013 [cited 2016 Feb 18].
7. Tzialla C, Civardi E, Pozzi M, Stronati M. Antibiotics and multi-resistant organisms. Ital J Pediatr. 2015 Sep;41(Suppl. 1):A45. [CrossRef]
8. Peterson L, Diekema D. To screen or not to screen for methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2010 Mar;48(3):683-9. [PubMed]
9. Marlowe EM, Bankowski MJ. Conventional and Molecular Methods for the Detection of Methicillin-Resistant Staphylococcus aureus. J Clin Microbiol. 2011 Sep; 49(9 Suppl):S53-6. [CrossRef]
10. Malhotra-Kumar S, Abrahantes J, Sabiiti W, Lammens C, Vercauteren G, Ieven M, et al. Evaluation of chromogenic media for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2010 Apr;48(4):1040-6. [PubMed]
11. Harbarth S, Hawkey P, Tenover F, Stefani S, Pantosti A, Struelens M. Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 2011 Feb;37(2):110-7. [PubMed]
12. Peterson J, Riebe K, Hall G, Wilson D, Whittier S, Palavecino E, et al. Spectra MRSA, a new chromogenic agar medium to screen for methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2010 Jan;48(1):215-9. [PubMed]
13. ORSAB Selective Supplement. TOKU-E Application Data Sheet. [Internet]. [cited 2016 Feb 18].
14. BD (Becton D and C. Diagnostic Systems: BBLTM CHROMagar® MRSA II [Internet]. [cited 2016 Feb 19].
15. Felten A, Grandry B, Lagrange P, Casin I. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol. 2002 Aug;40(8):2766–71. [PubMed]
16. Sakoulas G, Gold H, Venkataraman L, DeGirolami P, Eliopoulos G, Qian Q. Methicillin-Resistant Staphylococcus aureus: Comparison of Susceptibility Testing Methods and Analysis of mecA-Positive Susceptible Strains. J Clin Microbiol. 2001 Nov;39(11):3946–51. [PubMed].

Received: 11 April 2016
Published online: 15 June 2016

back to Online Journal